Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin issues patent update on fish-oil drug
Marketwatch
Wednesday, September 5, 2012 - 12:37pm
tags:
Amarin, patents, fish oil, Vascepa
FDA sets priority review for J&J tuberculosis drug
Yahoo/AP
Wednesday, September 5, 2012 - 11:53am
tags:
JNJ, tuberculosis, FDA, TMC207
Eli Lilly: New Drug Nightmares Will Sink Stock In 2013
Seeking Alpha
Wednesday, September 5, 2012 - 11:50am
tags:
Eli Lilly, Teva Pharmaceuticals, Pfizer, Mylan, Bristol-Myers Squibb
Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies
NASDAQ.com
Wednesday, September 5, 2012 - 10:58am
tags:
Roche, R&D
Glaxo Studies Three-In-One Emphysema Medicine to Keep Lead
Bloomberg Businessweek
Wednesday, September 5, 2012 - 10:57am
tags:
GSK, emphysema, GSK961081
Is The FDA Sacrificing Safety For Speed?
Pharmalot
Wednesday, September 5, 2012 - 10:55am
tags:
drug approvals, FDA
Cashed Up Biotech Vanda Could Keep On Falling
Seeking Alpha
Wednesday, September 5, 2012 - 10:44am
tags:
Vanda, Eli Lilly, Novartis, Bristol-Myers Squibb, Takeda
Valeant Leaps to No. 1 in Dermatology With Medicis Buy
Motley Fool
Wednesday, September 5, 2012 - 10:42am
tags:
dermatology, M&A, Valeant Pharmaceuticals, Medicis
Danish Survey Finds Clopidogrel Less Effective In Diabetics
Forbes
Wednesday, September 5, 2012 - 10:41am
tags:
Clopidogrel, diabetes
The Wait Goes On At YM Biosciences
Seeking Alpha
Wednesday, September 5, 2012 - 10:41am
tags:
YM BioSciences, Incyte, Sanofi, JNJ, Novartis, CYT387
US FDA approves Pfizer leukemia drug
Reuters
Wednesday, September 5, 2012 - 10:39am
tags:
FDA, Pfizer, leukemia, Bosulif, chronic myelogenous leukemia
Sanofi signals Lemtrada confidence with CVR buyback
Reuters
Tuesday, September 4, 2012 - 5:25pm
tags:
CVRs, Sanofi, Lemtrada, MS, multiple sclerosis
MannKind fall after registering possible stock and debt offering worth up to $500M
Yahoo/AP
Tuesday, September 4, 2012 - 5:23pm
tags:
stock offering, MannKind
3 Vaccine Companies With Near Term Catalysts
Seeking Alpha
Tuesday, September 4, 2012 - 5:22pm
tags:
vaccines, Celldex, Novavax, Inovio
Allergan Opens New Research and Development Center in Bridgewater, New Jersey
Yahoo
Tuesday, September 4, 2012 - 5:21pm
tags:
Allergan, R&D, New Jersey
Santarus Can Pursue Some Patent Claims Over Zegerid Copy
Bloomberg
Tuesday, September 4, 2012 - 1:12pm
tags:
Santarus, patents, Zegerid
Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tuesday, September 4, 2012 - 12:27pm
tags:
Gilead, Salix, Peregrine Pharmaceuticals, Navidea Biopharmaceuticals, Crofelemer, tobramycin, Lymphoseek, bavituximab, Truvada, Eylea, Regeneron, lixivaptan, Cornerstone Therapeutics
Pfizer cancer pill Inlyta gets EU approval for kidney cancer after failure of first treatment
Yahoo/AP
Tuesday, September 4, 2012 - 12:24pm
tags:
Pfizer, kidney cancer, Inlyta, Europe
Rigel Pharma: Key RA Drug Data Expected Late 2012 Through H1 2013
Seeking Alpha
Tuesday, September 4, 2012 - 12:22pm
tags:
Rigel Pharmaceuticals, rheumatoid arthritis, fostamatinib
Substandard APIs will be made as long as Pharmas keep buying them, says WHO
in-Pharma Technologist
Tuesday, September 4, 2012 - 12:19pm
tags:
WHO, APIs, China, active pharmaceutical ingredients, drug manufacturing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.